Denali Therapeutics (DNLI) Long-Term Deferred Tax (2018)
Denali Therapeutics (DNLI) has disclosed Long-Term Deferred Tax for 1 consecutive years, with $23.5 million as the latest value for Q1 2018.
Denali Therapeutics (DNLI) has disclosed Long-Term Deferred Tax for 1 consecutive years, with $23.5 million as the latest value for Q1 2018.
| Date | Value |
|---|---|
Offer Ends In
Starting from $49 $19 / month